EP0891335A4 - Inhibiteurs de transferase de farnesyl-proteine - Google Patents
Inhibiteurs de transferase de farnesyl-proteineInfo
- Publication number
- EP0891335A4 EP0891335A4 EP97917759A EP97917759A EP0891335A4 EP 0891335 A4 EP0891335 A4 EP 0891335A4 EP 97917759 A EP97917759 A EP 97917759A EP 97917759 A EP97917759 A EP 97917759A EP 0891335 A4 EP0891335 A4 EP 0891335A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- farnesyl
- inhibitors
- protein transferase
- transferase
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/84—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/88—Nitrogen atoms, e.g. allantoin
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Urology & Nephrology (AREA)
- Oncology (AREA)
- Virology (AREA)
- Ophthalmology & Optometry (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US1479496P | 1996-04-03 | 1996-04-03 | |
US14794P | 1996-04-03 | ||
GBGB9609334.9A GB9609334D0 (en) | 1996-05-03 | 1996-05-03 | Inhibitors of farnesyl-protein transferase |
GB9609334 | 1996-05-03 | ||
PCT/US1997/005295 WO1997036877A1 (fr) | 1996-04-03 | 1997-03-31 | Inhibiteurs de transferase de farnesyl-proteine |
Publications (2)
Publication Number | Publication Date |
---|---|
EP0891335A1 EP0891335A1 (fr) | 1999-01-20 |
EP0891335A4 true EP0891335A4 (fr) | 2001-08-16 |
Family
ID=26309267
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP97917759A Withdrawn EP0891335A4 (fr) | 1996-04-03 | 1997-03-31 | Inhibiteurs de transferase de farnesyl-proteine |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0891335A4 (fr) |
JP (1) | JP2000507589A (fr) |
AU (1) | AU707416B2 (fr) |
CA (1) | CA2250460A1 (fr) |
WO (1) | WO1997036877A1 (fr) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA981080B (en) | 1997-02-11 | 1998-08-12 | Warner Lambert Co | Bicyclic inhibitors of protein farnesyl transferase |
NZ509241A (en) | 1998-08-07 | 2003-08-29 | Du Pont Pharm Co | Succinoylamino lactams as inhibitors of alpha-beta protein production |
HRP990246A2 (en) | 1998-08-07 | 2000-06-30 | Du Pont Pharm Co | Succinoylamino benzodiazepines as inhibitors of a beta protein production |
AU778005B2 (en) | 1998-12-24 | 2004-11-11 | Bristol-Myers Squibb Pharma Company | Succinoylamino benzodiazepines as inhibitors of Abeta protein production |
US6960576B2 (en) | 1999-09-13 | 2005-11-01 | Bristol-Myers Squibb Pharma Company | Hydroxyalkanoylaminolactams and related structures as inhibitors of Aβ protein production |
US6503902B2 (en) | 1999-09-13 | 2003-01-07 | Bristol-Myers Squibb Pharma Company | Hydroxyalkanoylaminolactams and related structures as inhibitors of a β protein production |
CA2384544A1 (fr) | 1999-10-08 | 2001-04-19 | Bristol-Myers Squibb Pharma Company | Amino sulfonamides de lactame utilises comme inhibiteurs de la production de proteine a.beta. |
EP1261610A2 (fr) | 2000-02-17 | 2002-12-04 | Bristol-Myers Squibb Pharma Company | CARBOCYCLES ET HETEROCYCLES SUCCINOYLAMINO UTILISES EN TANT QU'INHIBITEURS DE LA PRODUCTION DE LA PROTEINE A$g(b) |
MXPA02009755A (es) | 2000-04-03 | 2003-03-27 | Bristol Myers Squibb Pharma Co | Lactamas ciclicas como inhibidores de la produccion de proteina a-beta. |
AU2001253108A1 (en) | 2000-04-03 | 2001-10-15 | Bristol-Myers Squibb Pharma Company | Cyclic lactams as inhibitors of a-beta protein production |
WO2001077086A1 (fr) | 2000-04-11 | 2001-10-18 | Dupont Pharmaceuticals Company | LACTAMES SUBSTITUES UTILISES EN TANT QU'INHIBITEURS DE PRODUCTION DE PROTEINE A$g(b) |
NZ516746A (en) | 2000-06-01 | 2004-02-27 | Bristol Myers Squibb Pharma | Lactams substituted by cyclic succinates as inhibitors of A-beta protein production |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0675112A1 (fr) * | 1994-03-31 | 1995-10-04 | Bristol-Myers Squibb Company | Inhibiteurs de farnésyl-protéine-transférase contenant l'imidazole |
WO1996010034A2 (fr) * | 1994-09-29 | 1996-04-04 | Merck & Co., Inc. | Inhibiteurs de la transferase de proteines farnesylees exempts de thiol |
WO1996030015A1 (fr) * | 1995-03-29 | 1996-10-03 | Merck & Co., Inc. | Inhibiteurs de farnesyl-proteine transferase |
WO1996030343A1 (fr) * | 1995-03-29 | 1996-10-03 | Merck & Co., Inc. | Inhibiteurs de farnesyl-proteine transferase |
WO1996037204A1 (fr) * | 1995-05-24 | 1996-11-28 | Merck & Co., Inc. | Inhibiteurs de la farnesyle-proteine transferase |
WO1997036583A1 (fr) * | 1996-04-03 | 1997-10-09 | Merck & Co., Inc. | Inhibiteurs de la farnesyle-proteine transferase |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4853383A (en) * | 1975-03-03 | 1989-08-01 | Merck & Co., Inc. | β-blocking substituted imidazoles |
JPH06510762A (ja) * | 1991-08-19 | 1994-12-01 | イー・アイ・デュポン・ドゥ・ヌムール・アンド・カンパニー | アンジオテンシン2受容体遮断イミダゾリノン誘導体 |
US5401851A (en) * | 1992-06-03 | 1995-03-28 | Eli Lilly And Company | Angiotensin II antagonists |
US5534537A (en) * | 1995-03-29 | 1996-07-09 | Merck & Co., Inc. | Prodrugs of inhibitors of farnesyl-protein transferase |
-
1997
- 1997-03-31 WO PCT/US1997/005295 patent/WO1997036877A1/fr not_active Application Discontinuation
- 1997-03-31 AU AU26005/97A patent/AU707416B2/en not_active Ceased
- 1997-03-31 CA CA002250460A patent/CA2250460A1/fr not_active Abandoned
- 1997-03-31 EP EP97917759A patent/EP0891335A4/fr not_active Withdrawn
- 1997-03-31 JP JP9535531A patent/JP2000507589A/ja active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0675112A1 (fr) * | 1994-03-31 | 1995-10-04 | Bristol-Myers Squibb Company | Inhibiteurs de farnésyl-protéine-transférase contenant l'imidazole |
WO1996010034A2 (fr) * | 1994-09-29 | 1996-04-04 | Merck & Co., Inc. | Inhibiteurs de la transferase de proteines farnesylees exempts de thiol |
WO1996030015A1 (fr) * | 1995-03-29 | 1996-10-03 | Merck & Co., Inc. | Inhibiteurs de farnesyl-proteine transferase |
WO1996030343A1 (fr) * | 1995-03-29 | 1996-10-03 | Merck & Co., Inc. | Inhibiteurs de farnesyl-proteine transferase |
WO1996037204A1 (fr) * | 1995-05-24 | 1996-11-28 | Merck & Co., Inc. | Inhibiteurs de la farnesyle-proteine transferase |
WO1997036583A1 (fr) * | 1996-04-03 | 1997-10-09 | Merck & Co., Inc. | Inhibiteurs de la farnesyle-proteine transferase |
Non-Patent Citations (2)
Title |
---|
GRAHAM,S.L.: "Inhibitors of protein farnesylation: a new approach to cancer chemotherapy", EXP.OPIN.THER.PATENTS, vol. 5, no. 12, 1995, LONDON, pages 1269 - 1285, XP001000610 * |
See also references of WO9736877A1 * |
Also Published As
Publication number | Publication date |
---|---|
AU707416B2 (en) | 1999-07-08 |
EP0891335A1 (fr) | 1999-01-20 |
CA2250460A1 (fr) | 1997-10-09 |
AU2600597A (en) | 1997-10-22 |
JP2000507589A (ja) | 2000-06-20 |
WO1997036877A1 (fr) | 1997-10-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0891350A4 (fr) | Inhibiteurs de farnesyle-proteine transferase | |
EP1011669A4 (fr) | Inhibiteurs de la farnesyl-proteine transferase | |
GB9604311D0 (en) | Inhibitors of farnesyl-protein transferase | |
EP0891360A4 (fr) | Inhibiteurs de la farnesyl-proteine transferase | |
EP1045844A4 (fr) | Inhibiteurs de farnesyl-proteine transferase | |
EP0904080A4 (fr) | Inhibiteurs de farnesyle-proteine transferase | |
EP0880320A4 (fr) | Inhibiteurs de la farnesyl-proteine transferase | |
EP0891349A4 (fr) | Inhibiteurs de farnesyl-proteine transferase | |
EP0891352A4 (fr) | Inhibiteurs de la farnesyl-proteine transferase | |
EP1035850A4 (fr) | Inhibiteurs de la transferase de la farnesyl-proteine | |
EP1035852A4 (fr) | Inhibiteurs de la farnesyl-proteine transferase | |
EP0891335A4 (fr) | Inhibiteurs de transferase de farnesyl-proteine | |
EP0891353A4 (fr) | Inhibiteurs de farnesyle-proteine transferase | |
EP0959883A4 (fr) | Inhibiteurs de la farnesyle-proteine transferase | |
EP1035849A4 (fr) | Inhibiteurs de la transferase de la farnesyl-proteine | |
EP0877610A4 (fr) | Inhibiteurs de farnesyl-proteine transferase | |
EP1023270A4 (fr) | Inhibiteurs de farnesyl-proteine transferase | |
EP0900081A4 (fr) | Inhibiteurs de farnesyl-proteine transferase | |
GB9721000D0 (en) | Inhibitors of farnesyl-protein transferase | |
GB9617280D0 (en) | Inhibitors of farnesyl-protein transferase | |
GB9614315D0 (en) | Inhibitors of farnesyl-protein transferase | |
GB9624169D0 (en) | Inhibitors of farnesyl-protein transferase | |
GB9617282D0 (en) | Inhibitors of farnesyl-protein transferase | |
GB9605157D0 (en) | Inhibitors of farnesyl-protein transferase | |
GB9605708D0 (en) | Inhibitors of farnesyl-protein transferase |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19981103 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20010703 |
|
AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20010928 |